Literature DB >> 26017329

The first pure form of Ostertag-type amyloidosis in Japan: a sporadic case of hereditary fibrinogen Aα-chain amyloidosis associated with a novel frameshift variant.

Masahide Yazaki1, Tsuneaki Yoshinaga, Yoshiki Sekijima, Saori Nishio, Yuji Kanizawa, Fuyuki Kametani, Kana Miyashita, Naomi Hachiya, Keiichi Higuchi, Shu-ichi Ikeda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26017329     DOI： 10.3109/13506129.2015.1037389

Source DB:  PubMed          Journal:  Amyloid        ISSN： 1350-6129            Impact factor:   7.141


× No keyword cloud information.
  5 in total

1.  VLITL is a major cross-β-sheet signal for fibrinogen Aα-chain frameshift variants.

Authors:  Cyrille Garnier; Fatma Briki; Brigitte Nedelec; Patrick Le Pogamp; Ahmet Dogan; Nathalie Rioux-Leclercq; Renan Goude; Caroline Beugnet; Laurent Martin; Marc Delpech; Frank Bridoux; Gilles Grateau; Jean Doucet; Philippe Derreumaux; Sophie Valleix
Journal:  Blood       Date:  2017-10-31       Impact factor: 22.113

Review 2.  Fibrinogen alpha amyloidosis: insights from proteomics.

Authors:  Jessica Chapman; Ahmet Dogan
Journal:  Expert Rev Proteomics       Date:  2019-08-28       Impact factor: 3.940

Review 3.  Hereditary Fibrinogen Aα-Chain Amyloidosis in Asia: Clinical and Molecular Characteristics.

Authors:  Masahide Yazaki; Tsuneaki Yoshinaga; Yoshiki Sekijima; Fuyuki Kametani; Nobuo Okumura
Journal:  Int J Mol Sci       Date:  2018-01-22       Impact factor: 5.923

4.  Fibrinogen A Alpha-Chain Amyloidosis in Two Chinese Patients.

Authors:  Zhen-Yu Li; Shuang Wang; Dan-Yang Li; Dan Liu; Su-Xia Wang; Xiao-Juan Yu; Gang Liu; Fu-De Zhou; Ming-Hui Zhao
Journal:  Front Med (Lausanne)       Date:  2022-04-28

5.  Giant Hepatomegaly with Spleno-testicular Enlargement in a Patient with Apolipoprotein A-I Amyloidosis: An Uncommon Type of Amyloidosis in Japan.

Authors:  Tsuneaki Yoshinaga; Nagaaki Katoh; Masahide Yazaki; Mitsuto Sato; Fuyuki Kametani; Hideo Yasuda; Kyohei Watanabe; Kazuhito Kawata; Mayuko Nakagawa; Yoshiki Sekijima
Journal:  Intern Med       Date:  2020-09-30       Impact factor: 1.271
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.